NextCure Inc
F:2US
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCure Inc
F:2US
|
US |
|
Gelsenwasser AG
F:WWG
|
DE |
|
Brainstorm Cell Therapeutics Inc
OTC:BCLI
|
US |
|
Moulinvest SA
PAR:ALMOU
|
FR |
|
A
|
Adams Resources & Energy Inc
AMEX:AE
|
US |
|
Enviva Inc
NYSE:EVA
|
US |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
Kelso Technologies Inc
TSX:KLS
|
CA |
|
F
|
Fort St James Nickel Corp
XTSX:FTJ
|
CA |
|
T
|
Tongyang Pile Inc
KOSDAQ:228340
|
KR |
|
Imperial Metals Corp
TSX:III
|
CA |
|
Astral Foods Ltd
OTC:ALFDF
|
ZA |
|
Lions Gate Entertainment Corp
NASDAQ:STRZ
|
US |
|
AYRO Inc
NASDAQ:AYRO
|
US |
|
A
|
Allegro.eu SA
WSE:ALE
|
LU |
|
H
|
Huddly AS
OSE:HDLY
|
NO |
|
Roche Holding AG
SIX:ROG
|
CH |
|
Centuria Office REIT
ASX:COF
|
AU |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
Thomson Medical Group Ltd
SGX:A50
|
SG |
|
Austevoll Seafood ASA
OSE:AUSS
|
NO |
|
Acanthe Developpement SE
PAR:ACAN
|
FR |
|
Elia Group SA
OTC:ELIAF
|
BE |
|
I
|
Imperial Oil Ltd
F:IMP
|
CA |
Wall St Price Targets
2US Price Targets Summary
NextCure Inc
According to Wall Street analysts, the average 1-year price target for 2US is 12.448 EUR with a low forecast of 10.565 EUR and a high forecast of 14.644 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2US's stock price target?
Price Target
12.448
EUR
According to Wall Street analysts, the average 1-year price target for 2US is 12.448 EUR with a low forecast of 10.565 EUR and a high forecast of 14.644 EUR.